Items where authors include "Hughes, S."

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 14.

Article

Steinberg, S., Hughes, S., Hui, H. et al. (59 more authors) (2024) Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: a systematic review and meta-analysis. International Journal of Cancer, 154 (8). pp. 1394-1412. ISSN 0020-7136

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Paddock, R. W., Li, T. S., Kim, E. et al. (25 more authors) (2024) Energy gain of wetted-foam implosions with auxiliary heating for inertial fusion studies. Plasma Physics and Controlled Fusion. 025005. ISSN 1361-6587

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Giovannoni, G., Ford, H.L., Schmierer, K. et al. (12 more authors) (2024) MS care: integrating advanced therapies and holistic management. Frontiers in Neurology, 14. ARTN 1286122. ISSN 1664-2295

Michael, B.D. orcid.org/0000-0002-8693-8926, Dunai, C. orcid.org/0000-0001-5799-2387, Needham, E.J. orcid.org/0000-0001-7042-7462 et al. (559 more authors) (2023) Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses. Nature Communications, 14 (1). 8487. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Hughes, S., Kunin, W. orcid.org/0000-0002-9812-2326, Ziv, G. orcid.org/0000-0002-6776-0763 et al. (1 more author) (2023) Spatial targeting of woodland creation can reduce the colonisation credit of woodland plants. Ecological Solutions and Evidence, 4 (3). e12263. ISSN 2688-8319

Solovyeva, O. orcid.org/0000-0001-7828-4099, Dimairo, M. orcid.org/0000-0002-9311-6920, Weir, C.J. orcid.org/0000-0002-6494-4903 et al. (20 more authors) (2023) Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study. BMC Medicine, 21 (1). 246. ISSN 1741-7015

Kalincik, T., Sharmin, S., Roos, I. et al. (150 more authors) (2023) Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis. JAMA Neurology, 80 (7). pp. 702-713. ISSN 2168-6149

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736

Hill, J., Lee, S., Morton, D. et al. (543 more authors) (2022) Colorectal Endoscopic Stenting Trial (CReST) for obstructing left-sided colorectal cancer: randomized clinical trial. British Journal of Surgery, 109 (11). pp. 1073-1080. ISSN 0007-1323

Tuijnenburg, P., Lango Allen, H., Burns, S.O. et al. (85 more authors) (2018) Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. Journal of Allergy and Clinical Immunology, 142 (4). pp. 1285-1296. ISSN 0091-6749

De Silva, S., Barnard, A., Hughes, S. et al. (9 more authors) (2017) Long-term restoration of visual function in end-stage retinal degeneration using subretinal human melanopsin gene therapy. Proceedings of the National Academy of Sciences, 114 (42). pp. 11211-11216. ISSN 1091-6490

This list was generated on Sat Apr 20 21:33:25 2024 BST.